Long-term active surveillance for prostate cancer: answers and questions
This 2014 editorial by Dr. Matthew R. Cooperberg discusses the evolving role of active surveillance (AS) in managing low-risk prostate cancer. It emphasizes that AS is a viable strategy to avoid overtreatment and associated morbidities in men with indolent disease. The article highlights the need for standardized AS protocols, including
June 26, 2025
No Comments